Bring Your Bunch for Blessings in the Bottoms, Nov. 6-8
Kansas City's historic West Bottoms serves up vintage treasures, friend-filled giveaways, frozen turkey bowling, free line dancing, and fireside fun...
Read moreDetails
Press Releases – Lifestyle
Beyond the Label of Solo Motherhood: TECNO and Angélica Dass Launch the Philippines Portrait Gallery for 100 Portraits of Becoming
The gallery brings together 20 Filipinos whose lives intersect with solo motherhood, revealing the diverse roles, relationships and ambitions that...
Read moreDetailsNCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit with SBS Law
LOS ANGELES, Oct. 25, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors...
Read moreDetailsHeybike Launches V1 Pro, a 72V Power Beast with 8,000W Peak Power and Bigger Attitude
ONTARIO, Calif., Oct. 23, 2026 /PRNewswire/ -- Heybike today announced the launch of the V1 Pro, a 72V electric dirt...
Read moreDetailsLG ELECTRONICS ACCELERATES COMMERCIAL LAUNDRY GROWTH IN EUROPE AT EXPODETERGO INTERNATIONAL 2026
Full Commercial Laundry Lineup and Connected Management Solutions Advance LG's European B2B ExpansionNews Summary LG Electronics is showcasing a commercial...
Read moreDetailsTin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
SINGAPORE, Oct. 26, 2026 /PRNewswire/ -- Ailytics, a vision AI startup that turns existing industrial CCTV into a real-time safety...
Read moreDetailsAntengene Presents Latest Clinical Results for ATG-022 and ATG-037 at ESMO 2026
SHANGHAI and HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global...
Read moreDetailsOASE+ and Elsevier Agree Next-Phase Read and Publish Agreement to Expand Open Access Publishing in Japan
A new three-year term removes the annual cap on open access publishing under the Read and Publish agreement and extends eligibility...
Read moreDetailsAscletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity
- ASC39, an oral small molecule selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.- ASC39...
Read moreDetails
Results of CARsgen’s Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026
SHANGHAI, Oct. 25, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR...
Read moreDetails